Compare Stocks: MPH, ACRL, W7L, and PTL

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MPH Medicure	C$1.02 -6.4%	C$1.14	C$0.99 ▼ C$1.80	C$10.46M	1.01	4,477 shs	10,000 shs
PTL Inspire 500 ETF	$193.49 +0.1%	$0.00	$189.17 ▼ $205.92	$101.58M	1.25	30,835 shs	1,840 shs

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MPH Medicure	+10.10%	+0.93%	-9.17%	-5.22%	-17.42%
PTL Inspire 500 ETF	+0.17%	+1.21%	+19,337,469,900.00%	+19,337,469,900.00%	+19,337,469,900.00%

A new way to collect income from stocks (Ad)

Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…

Click here to see me place one of these trades LIVE on camera.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
MPH Medicure	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PTL Inspire 500 ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
MPH Medicure	N/A	N/A	N/A	N/A
PTL Inspire 500 ETF	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
MPH Medicure	C$22.94M	0.46	C$0.41 per share	2.49	C$2.10 per share	0.49
PTL Inspire 500 ETF	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
MPH Medicure	C$1.08M	C$0.09	11.33	∞	N/A	4.71%	5.04%	2.49%	5/24/2024 (Estimated)
PTL Inspire 500 ETF	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Latest MPH, ACRL, W7L, and PTL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
4/8/2024	Q4 2023	MPH Medicure	N/A	-C$0.14	-C$0.14	-C$0.14	N/A	C$5.07 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
MPH Medicure	N/A	N/A	N/A	N/A	N/A
PTL Inspire 500 ETF	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
MPH Medicure	2.86	2.28	1.29
PTL Inspire 500 ETF	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
MPH Medicure	23.10%
PTL Inspire 500 ETF	N/A

Insider Ownership

Company	Insider Ownership
MPH Medicure	26.99%
PTL Inspire 500 ETF	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
MPH Medicure	N/A	10.25 million	N/A	Not Optionable
PTL Inspire 500 ETF	N/A	525,000	N/A	N/A

MPH, ACRL, W7L, and PTL Headlines

Source	Headline
	Inspire's newest faith-based ETF passes $100M AUM in 11 days prnewswire.com - April 24 at 6:30 AM
	Inspire Adds Low-Cost ETF to Faith-Focused Lineup etftrends.com - March 26 at 3:45 PM

Media Sentiment Over Time

Company Descriptions

Medicure

CVE:MPH

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.

Inspire 500 ETF

NYSEARCA:PTL

The Inspire 500 ETF (PTL) is an exchange-traded fund that is based on the Inspire 500 index, a market-cap-weighted index of 500 large-cap US stocks, selected based on the issuers proprietary criteria of biblical values.

Compare Stocks